Arbutus Biopharma Corp (ABUS) — Tangible Net Worth Ratio
Arbutus Biopharma Corp (ABUS) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($76.58 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Arbutus Biopharma Corp current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Arbutus Biopharma Corp Tangible Net Worth Ratio (1998–2025)
This chart shows how Arbutus Biopharma Corp's Tangible Net Worth Ratio has changed across 26 annual periods from 1998 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $76.58 Million with intangible assets of $0.00 USD. See operational self-sufficiency of Arbutus Biopharma Corp to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Arbutus Biopharma Corp (1998–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Arbutus Biopharma Corp from 1998 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Arbutus Biopharma Corp worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $76.58 Million | $0.00 | $94.62 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $97.37 Million | $0.00 | $131.71 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $106.02 Million | $0.00 | $144.40 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $136.85 Million | $0.00 | $195.42 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $169.44 Million | $0.00 | $204.49 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $101.97 Million | $0.00 | $137.08 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $72.74 Million | $0.00 | $105.53 Million | ▲ +21.9 pp |
| 2018 | 78.1% | $200.23 Million | $43.84 Million | $227.91 Million | ▲ +10.2 pp |
| 2017 | 67.9% | $182.50 Million | $58.60 Million | $237.20 Million | ▲ +16.9 pp |
| 2016 | 51.0% | $203.00 Million | $99.40 Million | $275.90 Million | ▲ +15.4 pp |
| 2015 | 35.6% | $547.68 Million | $352.64 Million | $712.29 Million | ▼ -64.4 pp |
| 2014 | 100.0% | $88.00 Million | $0.00 | $118.20 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $59.19 Million | $0.00 | $71.72 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $40.92 Million | $0.00 | $52.60 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $5.21 Million | $0.00 | $13.70 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $10.73 Million | $0.00 | $21.02 Million | ▲ +40.8 pp |
| 2009 | 59.2% | $35.44 Million | $14.47 Million | $41.95 Million | ▼ -7.2 pp |
| 2008 | 66.4% | $38.29 Million | $12.87 Million | $42.34 Million | ▼ -33.6 pp |
| 2007 | 100.0% | $18.37 Million | $0.00 | $24.83 Million | ▲ +0.0 pp |
| 2006 | 100.0% | $155.53K | $0.00 | $6.03 Million | ▲ +0.9 pp |
| 2003 | 99.1% | $43.38 Million | $390.25K | $50.73 Million | ▲ +0.2 pp |
| 2002 | 98.9% | $45.35 Million | $520.38K | $53.22 Million | ▲ +2.1 pp |
| 2001 | 96.8% | $61.49 Million | $2.00 Million | $67.60 Million | ▼ -0.6 pp |
| 2000 | 97.3% | $30.03 Million | $801.06K | $32.52 Million | ▼ -0.7 pp |
| 1999 | 98.0% | $26.88 Million | $532.01K | $28.80 Million | ▼ -0.5 pp |
| 1998 | 98.5% | $14.43 Million | $212.38K | $15.83 Million | — |